Teva Operations Poland sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-13
Share capital
22,220,000.00 PLN
Activity description

Teva Operations Poland operates in the pharmaceutical industry, covering generic and specialty medicines. Teva runs a manufacturing plant in Krakow, marking its 95th anniversary in 2026, and educational campaigns about migraine and bone health.

Registered address
Emilii Plater 53, 00-113 Warszawa, Poland
Branches
  • ul. Osmańska 12, 02-823 Warszawa
  • ul. Mogilska 80, 31-546 Kraków
Website
Social media
Electronic delivery address
AE:PL-22634-41117-RSUTC-17

Financials

Revenue history (in m)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 84 days for 2021). 5 of 6 audited by a statutory auditor.

  • 202513/08/2026
  • 202404/07/2025
  • 202308/07/2024
  • 202211/07/2023
  • 202107/10/2022
  • 202012/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing103 / 24,649
Top <1%
City · Warszawa127 / 56,955
Top <1%
Voivodeship · Mazowieckie152 / 77,195
Top <1%
Country · Poland341 / 298,026
Top <1%

Results vs industry

Revenue
This companyUSD 529.42mMedianUSD 917.74kAverageUSD 25.93m
Net profit
This companyUSD 77.74mMedianUSD 14.44kAverageUSD 2.78m
Operating costs
This companyUSD 426.08mMedianUSD 860.03kAverageUSD 21.46m
Assets
This companyUSD 328.76mMedianUSD 911.84kAverageUSD 31.78m

Offer

Certifications: GMP

Websites

  • teva.plLeki generyczne i specjalistyczne | firma farmaceutyczna Teva
    Google Tag ManagerCloudflare

Trademarks

The company holds 78 active trademarks registered with the Polish Patent Office. 235 marks have expired or were not registered. The first mark was filed in 1969.

MarkNumberClassesStatusProtected until
FLEGAMINA FAST JUNIOR (word)Z.5479035Protected Oct 6, 2032
FLEGAMINA FAST (word)Z.5479005Protected Oct 6, 2032
METFORMAX COMBI (word)Z.5389555Protected Jan 21, 2032
SUPREMIN COMFORT (word)Z.5117655Protected Mar 23, 2030
SUPREMIN MAX (word)Z.5117665Protected Mar 23, 2030
MarkProtected until
FLEGAMINA FAST JUNIOR (word)Oct 6, 2032
FLEGAMINA FAST (word)Oct 6, 2032
METFORMAX COMBI (word)Jan 21, 2032
SUPREMIN COMFORT (word)Mar 23, 2030
SUPREMIN MAX (word)Mar 23, 2030

Job offers

The company has its own careers page: teva.pl/youcareer.

Authorized Representatives

Ewa Agnieszka Królikowska age 48 – Vice President of the Management Board
Liron Weiss-Bazak – President of the Management Board
Katarzyna Siatka age 58 – Attorney-in-fact (joint)
Tatjana Sviderskė age 40 – Vice President of the Management Board

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Pliva Hrvatska D.o.o.
101$6,002,160.99100%

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$925.2K
Buildings and premises
$23.6M

MSiG notices

Publication dateEvent
Jul 19, 2011Commercial Companies Code notice
May 9, 2011Merger plan

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$11,704

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Adamed Pharma S.A.
Astrazeneca Pharma Poland sp. z o.o.
Bausch Health Poland sp. z o.o.
Fresenius Kabi Polska sp. z o.o.
Bristol-Myers Squibb Polska sp. z o.o.
Takeda Pharma sp. z o.o.
Zentiva Polska sp. z o.o.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Sandoz Polska sp. z o.o.
Polfarmex S.A.

Change history

DateEvent
2012-11-08Share capital increase
2011-07-01Address change
2011-04-07Name change
2006-11-14Share capital increase
2006-09-21Address change

FAQ

Last updated: 2026-10-07